Hurley Capital
ZBH icon

Hurley Capital’s Zimmer Biomet ZBH Stock Holding History

Hurley Capital’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.28K Hold
48
– – ﹤0.01% 459
2026
Q2 		$4.14K Hold
48
– – ﹤0.01% 477
2026
Q1 		$4.35K Hold
48
– – ﹤0.01% 465
2025
Q4 		$4.32K Buy
+48
New +$4.55K ﹤0.01% 440

Other funds holding ZBH

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Equity Investment Corp
Equity Investment Corp Atlanta, Georgia $5.3B AUM 8.71% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Sound Shore Management
Sound Shore Management Greenwich, Connecticut $3.2B AUM 19.02% 1-Year Est. Return
Thompson Siegel & Walmsley
Thompson Siegel & Walmsley Richmond, Virginia $5.37B AUM 3.99% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return

Hurley Capital's ZBH Position: Q3 2026 in Review

Hurley Capital held its Zimmer Biomet (ZBH) position steady in Q3 2026 at 48 shares worth $4.28K. The position accounts for ﹤0.01% of the portfolio, ranked #459.

Hurley Capital first reported a position in ZBH in Q4 2025 and has held it in 4 quarters since. The position peaked at $4.35K in Q1 2026. 494 funds tracked by Wall St. Rank hold ZBH as of Q3 2026.

  • Hurley Capital held 48 shares of Zimmer Biomet worth $4.28K as of Q3 2026.
  • Hurley Capital left its Zimmer Biomet share count unchanged in Q3 2026.
  • Zimmer Biomet made up ﹤0.01% of Hurley Capital's portfolio in Q3 2026, its #459 holding.
  • Hurley Capital first reported a position in Zimmer Biomet in Q4 2025 and has held it in 4 quarters since.
  • Hurley Capital's Zimmer Biomet position peaked at $4.35K in Q1 2026.
  • 494 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2026.

Based on Hurley Capital's 13F filing for Q3 2026, filed 5 Nov 2026.